• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向慢性淋巴细胞白血病的腺苷能轴:破坏肿瘤微环境的一种方法?

Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?

机构信息

Department of Medical Sciences, University of Turin School of Medicine & Italian Institute for Genomic Medicine (IIGM), via Nizza, 52, 10126 Torino, Italy.

出版信息

Int J Mol Sci. 2018 Apr 12;19(4):1167. doi: 10.3390/ijms19041167.

DOI:10.3390/ijms19041167
PMID:29649100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5979564/
Abstract

Targeting adenosine triphosphate (ATP) metabolism and adenosinergic signaling in cancer is gaining momentum, as increasing evidence is showing their relevance in tumor immunology and biology. Chronic lymphocytic leukemia (CLL) results from the expansion of a population of mature B cells that progressively occupies the bone marrow (BM), the blood, and peripheral lymphoid organs. Notwithstanding significant progress in the treatment of these patients, the cure remains an unmet clinical need, suggesting that novel drugs or drug combinations are needed. A unique feature of CLL is its reliance on micro-environmental signals for proliferation and cell survival. We and others have shown that the lymphoid niche, an area of intense interactions between leukemic and bystander non-tumor cells, is a typically hypoxic environment. Here adenosine is generated by leukemic cells, as well as by cells of myeloid origin, acting through autocrine and paracrine mechanisms, ultimately affecting tumor growth, limiting drug responses, and skewing the immune cells towards a tolerant phenotype. Hence, understanding the mechanisms through which this complex network of enzymes, receptors, and metabolites functions in CLL, will pave the way to the use of pharmacological agents targeting the system, which, in combination with drugs targeting leukemic cells, may get us one step closer to curing these patients.

摘要

针对三磷酸腺苷(ATP)代谢和腺苷能信号在癌症中的作用的研究正在兴起,越来越多的证据表明它们与肿瘤免疫学和生物学有关。慢性淋巴细胞白血病(CLL)是由成熟 B 细胞群体的扩张引起的,这些细胞逐渐占据骨髓(BM)、血液和外周淋巴器官。尽管这些患者的治疗取得了显著进展,但治愈仍然是一个未满足的临床需求,这表明需要新的药物或药物组合。CLL 的一个独特特征是其增殖和细胞存活依赖于微环境信号。我们和其他人已经表明,淋巴样龛位,即白血病细胞与旁观者非肿瘤细胞之间强烈相互作用的区域,是一个典型的低氧环境。在这里,腺苷由白血病细胞以及髓系来源的细胞产生,通过自分泌和旁分泌机制起作用,最终影响肿瘤生长、限制药物反应,并使免疫细胞向耐受表型倾斜。因此,了解这个复杂的酶、受体和代谢物网络在 CLL 中的作用机制,将为使用针对该系统的药理制剂铺平道路,这些制剂与针对白血病细胞的药物联合使用,可能使我们更接近治愈这些患者的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/d109da5ebb2b/ijms-19-01167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/a055d3ab5024/ijms-19-01167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/8c7a2a21e91e/ijms-19-01167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/d109da5ebb2b/ijms-19-01167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/a055d3ab5024/ijms-19-01167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/8c7a2a21e91e/ijms-19-01167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/5979564/d109da5ebb2b/ijms-19-01167-g003.jpg

相似文献

1
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?靶向慢性淋巴细胞白血病的腺苷能轴:破坏肿瘤微环境的一种方法?
Int J Mol Sci. 2018 Apr 12;19(4):1167. doi: 10.3390/ijms19041167.
2
Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia.靶向慢性淋巴细胞白血病中腺苷的肿瘤促进作用。
Crit Rev Oncol Hematol. 2018 Jun;126:24-31. doi: 10.1016/j.critrevonc.2018.03.022. Epub 2018 Mar 29.
3
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.慢性淋巴细胞白血病中的免疫反应功能障碍:解析分子机制和微环境条件。
Int J Mol Sci. 2020 Mar 6;21(5):1825. doi: 10.3390/ijms21051825.
4
NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.慢性淋巴细胞白血病中的 NF-κB 激活:外部触发因素和内在病变的交汇点。
Semin Cancer Biol. 2016 Aug;39:40-8. doi: 10.1016/j.semcancer.2016.07.005. Epub 2016 Aug 1.
5
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options.靶向慢性淋巴细胞白血病的微环境为其提供了新的治疗选择。
Cancer Lett. 2013 Jan 1;328(1):27-35. doi: 10.1016/j.canlet.2012.08.012. Epub 2012 Aug 19.
6
Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.肝细胞生长因子诱导慢性淋巴细胞白血病的生存及免疫抑制作用
Curr Mol Med. 2017;17(1):24-33. doi: 10.2174/1566524017666170220095838.
7
Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.慢性淋巴细胞白血病——发病机制和治疗中的微环境作用。
Br J Haematol. 2013 Jul;162(1):15-24. doi: 10.1111/bjh.12344. Epub 2013 Apr 25.
8
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.超越旁观者:慢性淋巴细胞白血病中的髓样细胞。
Mol Immunol. 2019 Jun;110:77-87. doi: 10.1016/j.molimm.2017.11.014. Epub 2017 Nov 22.
9
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment.腺苷信号传导介导慢性淋巴细胞白血病微环境中的缺氧反应。
Blood Adv. 2016 Nov 22;1(1):47-61. doi: 10.1182/bloodadvances.2016000984. eCollection 2016 Nov 29.
10
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.慢性淋巴细胞白血病中的 T 细胞:一把双刃剑。
Front Immunol. 2021 Jan 20;11:612244. doi: 10.3389/fimmu.2020.612244. eCollection 2020.

引用本文的文献

1
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.T 细胞上的核苷酸酶 CD39 和 CD73:血液恶性肿瘤的新支柱。
Front Immunol. 2023 Jan 27;14:1110325. doi: 10.3389/fimmu.2023.1110325. eCollection 2023.
2
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis.具有非典型病程的非生发中心弥漫性大B细胞淋巴瘤:一例报告及临床外显子组分析
World J Oncol. 2022 Feb;13(1):38-47. doi: 10.14740/wjon1436. Epub 2022 Feb 8.
3
Cancer biology and molecular genetics of A adenosine receptor.

本文引用的文献

1
Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure.激活腺苷 A1 受体通过 ADORA1/PKC/KATP 通路加速间歇性低氧暴露后 PC12 细胞损伤。
Mol Cell Biochem. 2018 Sep;446(1-2):161-170. doi: 10.1007/s11010-018-3283-2. Epub 2018 Jan 29.
2
The Hypoxia-Adenosine Link during Intestinal Inflammation.肠道炎症中的缺氧-腺苷关联。
J Immunol. 2018 Feb 1;200(3):897-907. doi: 10.4049/jimmunol.1701414.
3
Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine.
A 腺苷受体的癌症生物学和分子遗传学。
Oncogene. 2022 Jan;41(3):301-308. doi: 10.1038/s41388-021-02090-z. Epub 2021 Nov 8.
4
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.血液恶性肿瘤中的细胞外核苷酸酶:表面标志物与治疗靶点的故事。
Front Immunol. 2019 Oct 4;10:2301. doi: 10.3389/fimmu.2019.02301. eCollection 2019.
缺氧肿瘤微环境中损害抗肿瘤免疫的共犯:腺苷、乳酸、酸中毒、血管内皮生长因子、钾离子和磷脂酰丝氨酸。
Front Immunol. 2017 Dec 21;8:1887. doi: 10.3389/fimmu.2017.01887. eCollection 2017.
4
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment.腺苷信号传导介导慢性淋巴细胞白血病微环境中的缺氧反应。
Blood Adv. 2016 Nov 22;1(1):47-61. doi: 10.1182/bloodadvances.2016000984. eCollection 2016 Nov 29.
5
The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.慢性淋巴细胞白血病的突变特征及其对预后和治疗的影响。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):329-337. doi: 10.1182/asheducation-2017.1.329.
6
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.P2X7 受体作为治疗靶点的潜力,包括炎症和肿瘤进展。
Purinergic Signal. 2018 Mar;14(1):1-18. doi: 10.1007/s11302-017-9593-0. Epub 2017 Nov 21.
7
Hypoxia-induced miR-214 expression promotes tumour cell proliferation and migration by enhancing the Warburg effect in gastric carcinoma cells.缺氧诱导的 miR-214 表达通过增强胃癌细胞的瓦博格效应促进肿瘤细胞增殖和迁移。
Cancer Lett. 2018 Feb 1;414:44-56. doi: 10.1016/j.canlet.2017.11.007. Epub 2017 Nov 10.
8
Targeting immunosuppressive adenosine in cancer.靶向肿瘤中的免疫抑制腺苷。
Nat Rev Cancer. 2017 Dec;17(12):709-724. doi: 10.1038/nrc.2017.86. Epub 2017 Oct 23.
9
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.慢性淋巴细胞白血病:2017 年诊断、风险分层和治疗更新。
Am J Hematol. 2017 Sep;92(9):946-965. doi: 10.1002/ajh.24826.
10
New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.针对慢性淋巴细胞白血病中反复出现的突变的新药发现方法。
Expert Opin Drug Discov. 2017 Oct;12(10):1041-1052. doi: 10.1080/17460441.2017.1362387. Epub 2017 Aug 4.